| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |